Study on Multibranched Stent Graft System in the Treatment of Thoracoabdominal Aortic Aneurysm

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorLifetech Scientific (Shenzhen) Co., Ltd.

About this trial

The objective of this study is to evaluate the feasibility of multibranched stent graft system for Endovascular Treatment of Thoracoabdominal Aortic Aneurysm(TAAA)

Eligibility criteria

Qualifiers

Age ≥18 and ≤80 years;

Maximum diameter of TAAA >50 mm,

Rapid growth of sac >5 mm in diameter in the most recent 6 months, or rapid growth >10 mm in diameter within 1 year

Symptoms related to thoracoabdominal aortic aneurysm, such as clear abdominal pain and back pain.

Disqualifiers

Ruptured aortic aneurysm in unstable haemodynamic condition;

Aneurysmal aortic dissection;

Infected or mycotic aortic aneurysm;

Patients whose systemic or local infection may increase the risk of intravascular graft infection;

Trial design

Treatments tested in this trial

  • multibranched stent graft system

Treatment groups

73 Participants
are divided into 1 treatment group